Susquehanna International Group
TRVI icon

Susquehanna International Group’s Trevi Therapeutics TRVI Stock Holding History

Susquehanna International Group’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72M Sell
227,688
-597,860
-72% -$6.69M ﹤0.01% 5483
2025
Q4 		$10.3M Sell
825,548
-775,194
-48% -$8.96M ﹤0.01% 2999
2025
Q3 		$14.6M Buy
1,600,742
+1,473,157
+1,155% +$11M ﹤0.01% 2528
2025
Q2 		$698K Sell
127,585
-153,514
-55% -$955K ﹤0.01% 8361
2025
Q1 		$1.77M Buy
281,099
+240,491
+592% +$1.15M ﹤0.01% 5806
2024
Q4 		$167K Buy
40,608
+230
+0.6% +$736 ﹤0.01% 10923
2024
Q3 		$135K Buy
+40,378
New +$120K ﹤0.01% 10837
2024
Q1 		– Sell
-17,207
Closed -$23.1K – 13345
2023
Q4 		$23.1K Buy
+17,207
New +$26.1K ﹤0.01% 11947
2023
Q3 		– Sell
-11,571
Closed -$27.7K – 13007
2023
Q2 		$27.7K Sell
11,571
-16,095
-58% -$40.6K ﹤0.01% 11548
2023
Q1 		$51.2K Buy
+27,666
New +$62.6K ﹤0.01% 11695
2021
Q1 		– Sell
-14,828
Closed -$36K – 12869
2020
Q4 		$36K Buy
+14,828
New +$48K ﹤0.01% 10816

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return